Using GHD and TS patients a large candidate gene study of response to r-hGH during the first year of treatment has been conducted that examined genetic variation in 103 genes within i) the GH/IGF1 axis, ii) bone and cell growth and iii) glucose and lipid metabolism pathways, as either core growth pathways or pathways immediately related to growth. Here, GH1 is linked to Timothy syndrome.